HR Execs on the Move

Millendo

www.millendo.com

 
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing`s Syndrome (CS).
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.millendo.com
  • 301 N. Main Street Suite 100
    Ann Arbor, MI USA 48104
  • Phone: 734.845.9000

Executives

Name Title Contact Details
Jeffery Brinza
 Chief Administrative Officer and General Counsel Profile

Similar Companies

Nonlethal Technologies

Nonlethal Technologies, Inc is a Homer City, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

kinetix pharm

kinetix pharm is a Medford, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

EnteraTech

EnteraTech is a Hilliard, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Fog Pharmaceuticals

FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered `undruggable`.

Oxford Finance Corporation

Oxford Finance Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.